-
Je něco špatně v tomto záznamu ?
Modeling the influence of non-adherence on antibiotic efficacy: application to ciprofloxacin
P Lansky, P Sanda, M Weiss
Jazyk angličtina Země Německo
Grantová podpora
NR7795
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Medline Complete (EBSCOhost)
od 2005-01-01 do 2014-10-31
PubMed
17725177
DOI
10.5414/cpp45438
Knihovny.cz E-zdroje
- MeSH
- algoritmy MeSH
- antibakteriální látky aplikace a dávkování farmakokinetika terapeutické užití MeSH
- bakteriální infekce farmakoterapie mikrobiologie MeSH
- biologická dostupnost MeSH
- ciprofloxacin aplikace a dávkování farmakokinetika terapeutické užití MeSH
- financování organizované MeSH
- lidé MeSH
- odmítnutí terapie pacientem statistika a číselné údaje MeSH
- plocha pod křivkou MeSH
- statistické modely MeSH
- stochastické procesy MeSH
- Check Tag
- lidé MeSH
OBJECTIVE: To evaluate the consequences for antibiotic efficacy of different types of poor adherence to a short-term dosing regimen. Ciprofloxacin was taken as an example. METHOD: A simulation study on a 2-compartment pharmacokinetic model and parameter estimates taken from the literature was performed. Two empirical efficacy measures as well as a specific pharmacodynamic model of the bacterial kill curve were used. Four patterns of non-adherence were investigated: dosage omission, irregular dosing intervals, delayed dosing and treatment discontinuation. RESULTS: Errors in timing of doses with a standard deviation less than 2 h had a minor effect on antibiotic efficacy. Dosage omission, in contrast, has a significant influence on the antibacterial effect of ciprofloxacin. CONCLUSIONS: non-adherence patterns are difficult to measure experimentally, thus, recommended dosing regimens should be sufficiently robust against most of the nonintentional disturbances.
Citace poskytuje Crossref.org
- 000
- 02714naa 2200409 a 4500
- 001
- bmc10012293
- 003
- CZ-PrNML
- 005
- 20130926100441.0
- 008
- 100521s2007 gw e eng||
- 009
- AR
- 024 __
- $a 10.5414/cpp45438 $2 doi
- 035 __
- $a (PubMed)17725177
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Lánský, Petr $7 xx0062306
- 245 10
- $a Modeling the influence of non-adherence on antibiotic efficacy: application to ciprofloxacin / $c P Lansky, P Sanda, M Weiss
- 314 __
- $a Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. lansky@biomed.cas.cz
- 520 9_
- $a OBJECTIVE: To evaluate the consequences for antibiotic efficacy of different types of poor adherence to a short-term dosing regimen. Ciprofloxacin was taken as an example. METHOD: A simulation study on a 2-compartment pharmacokinetic model and parameter estimates taken from the literature was performed. Two empirical efficacy measures as well as a specific pharmacodynamic model of the bacterial kill curve were used. Four patterns of non-adherence were investigated: dosage omission, irregular dosing intervals, delayed dosing and treatment discontinuation. RESULTS: Errors in timing of doses with a standard deviation less than 2 h had a minor effect on antibiotic efficacy. Dosage omission, in contrast, has a significant influence on the antibacterial effect of ciprofloxacin. CONCLUSIONS: non-adherence patterns are difficult to measure experimentally, thus, recommended dosing regimens should be sufficiently robust against most of the nonintentional disturbances.
- 650 _2
- $a algoritmy $7 D000465
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $x farmakokinetika $x terapeutické užití $7 D000900
- 650 _2
- $a plocha pod křivkou $7 D019540
- 650 _2
- $a bakteriální infekce $x farmakoterapie $x mikrobiologie $7 D001424
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a ciprofloxacin $x aplikace a dávkování $x farmakokinetika $x terapeutické užití $7 D002939
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a statistické modely $7 D015233
- 650 _2
- $a stochastické procesy $7 D013269
- 650 _2
- $a odmítnutí terapie pacientem $x statistika a číselné údaje $7 D016312
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Šanda, Pavel $7 xx0127126
- 700 1_
- $a Weiss, M
- 773 0_
- $t International Journal of Clinical Pharmacology & Therapeutics $w MED00002304 $g Roč. 45, č. 8 Aug (2007), s. 438-447 $x 0946-1965
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100530074615 $b ABA008
- 991 __
- $a 20130926100953 $b ABA008
- 999 __
- $a ok $b bmc $g 726150 $s 589303
- BAS __
- $a 3
- BMC __
- $a 2007 $b 45 $c 8 Aug $d 438-447 $i 0946-1965 $m International journal of clinical pharmacology and therapeutics $n Int J Clin Pharmacol Ther $x MED00002304
- GRA __
- $a NR7795 $p MZ0
- LZP __
- $a 2010-B2/vtme